HLB INC.

028300· KOSDAQ· Health Care· Health Care Equipment & Services

₩34,350+11.17%

2026-08-04

Financials

Valuation Metrics

HLB INC.'s Market Cap is ₩4.6T. At end of 2025 it was ₩6.8T. Ranked #109 of 2,436 in KR market (top 4%), #8 of 1,649 on KOSDAQ (top 0.5%), #1 of 96 in Health Care Equipment & Services (top 1%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	4.58T KRW	KR#109/2,436 Sec#1/96
Revenue	85.20B KRW	KR#1,498/2,436 Sec#40/96
Net Income	-207.39B KRW	KR—/2,436 Sec—/96
Total Assets	925.44B KRW	KR#489/2,436 Sec#6/96
Net Assets	493.87B KRW	KR#502/2,436 Sec#8/96
Employees	168	KR#1,219/2,436 Sec#40/96
Value
P/B	9.26x	KR#2,337/2,436 Sec#91/96
P/S	53.70x	KR#2,368/2,436 Sec#95/96
FCF Yield	-2.39%	KR—/2,436 Sec—/96
Profitability
ROE	-41.99%	KR#2,240/2,436 Sec#82/96
ROA	-22.41%	KR#2,246/2,436 Sec#80/96
Op. Margin	-115.79%	KR#2,320/2,436 Sec#86/96
Revenue Growth	5.80%	KR#1,127/2,436 Sec#56/96
Financial Health
Debt Ratio	87.39%	KR#286/2,436 Sec#11/96
FCF	-109.53B KRW	KR#2,147/2,436 Sec#85/96
Cash	26.18B KRW	KR#1,079/2,436 Sec#21/96
Current Ratio	0.28x	KR#2,332/2,436 Sec#95/96
Performance
1Y Return	-28.21%	KR#1,521/2,436 Sec#47/96
1M Return	-28.96%	KR#2,349/2,436 Sec#93/96
From 52W High	-50.36%	KR#1,205/2,436 Sec#45/96
1Y MDD	-62.39%	KR#1,546/2,436 Sec#52/96
Trading
Volume	1,400,900 shares	KR#97/2,436 Sec#3/96
Foreign Own.	18.61%	KR#239/2,436 Sec#6/96
Per Share
EPS	-1,473 KRW	KR—/2,436 Sec—/96
BPS	3,123 KRW	KR#1,788/2,436 Sec#53/96

Company Info

CEO 진양곤, 백윤기 (각자대표)

Employees 168

Founded 1985

HQ 세종특별자치시 연동면, KR

Website hlbbio.co.kr

동사는 1985년 설립돼 1996년 코스닥에 상장한 바이오 의약품 회사로, 2023년 선박사업부를 물적분할해 HLB이엔지를 설립함. 헬스케어사업부는 체외진단 의료기기, 의약외품, 의료소모품을 제조·판매하고, Elevar와 Immunomic Therapeutics는 항암제 및 면역치료제를 개발하고 있음. 동사는 첨단 바이오 연구소 설립, 리보세라닙 치료제 FDA 승인 추진 등 혁신신약 개발로 글로벌 성장하고 있음. HLB는 1985년에 설립되었으며 세종특별자치시 연동면에 본사를 두고 있습니다.